Pathstone Holdings
IART icon

Pathstone Holdings’s Integra LifeSciences IART Stock Holding History

Pathstone Holdings’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,273
Closed -$468K – 2251
2025
Q1 		$468K Buy
21,273
+3,349
+19% +$78.7K ﹤0.01% 1746
2024
Q4 		$407K Buy
17,924
+4,571
+34% +$99.8K ﹤0.01% 1819
2024
Q3 		$243K Sell
13,353
-26,395
-66% -$612K ﹤0.01% 2084
2024
Q2 		$1.16M Hold
39,748
– – 0.01% 1241
2024
Q1 		$1.41M Buy
39,748
+24,794
+166% +$992K 0.01% 1073
2023
Q4 		$651K Buy
+14,954
New +$589K ﹤0.01% 1347

Other funds holding IART

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return